Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer

World Journal of Gastroenterology

Volumn 11, Issue 8, 2005, Pages 1193-1195

  Guzinska Ustymowicz, Katarzyna ^a   Kemona, Andrzej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Colorectal cancer; TGF ; Tumor budding

Indexed keywords

AVIDIN; MONOCLONAL ANTIBODY; PARAFFIN; PEROXIDASE; TRANSFORMING GROWTH FACTOR BETA;

ADENOCARCINOMA; ARTICLE; BIOTINYLATION; BLOOD VESSEL; CANCER INVASION; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; LYMPH NODE METASTASIS; MEDICAL PARAMETERS; METASTASIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

EID: 14844345809     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i8.1193     Document Type: Article

References (21)

1. Morodomi T, Isomoto H, Shirouzu G, Shirouzu K, Kakegawa K, Irie K, Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancers. Cancer 1989; 63: 539-543
2. Guzi ska-Ustymowicz K, Sulkowska M, Famulski W, Sulkowski S. Tumor budding and its relationship to p53 and bcl-2 expession in colorectal cancer. Anticancer Res 2003; 23: 649-654
3. Famulski W, Guzi ska-Ustymowicz K, Sulkowska M, Chabowski A, Zalewski B, Piotrowski Z, Stasiak-Barmuta A, Sulkowski S. Tumor budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer. Folia Histochem Cytobiol 2001; 39(Suppl 2): 171-172
4. Fujiwara T, Stolker JM, Watanabe T, Rashid A, Longo P, Eshleman JR, Booker S, Lynch HT, Jass JR, Green JS, Kim H, Jen J, Vogelstein B, Hamilton SR. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 1998; 153: 1063-1078
5. Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF β pathway in human cancers. Cytokine Growth Factor Rev 1996; 7: 93-102
6. Polyak K. Negative regulation of cell growth by TGF beta. Bichem Biophys Acta 1996; 1242: 185-199
7. Hsu S, Huang F, Hafez M, Winawer S, Friedman E. Colon carcinoma cells switch their response to transforming growth factor β with tumor progression. Cell Growth Differ 1994; 5: 267-275
8. Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor budding in patients with colorectal cancer. Dis Colon Rectum 1993; 36: 627-635
9. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumor 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002; 40: 127-132
10. Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in T1 or T2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum 2002; 45: 628-634
11. Okuyama T, Oya M, Yamaguchi M. Budding (Sprouting) as a useful prognostic marker in colorectal mucinous carcinoma. Jpn J Clin Oncol 2002; 32: 412-416
12. Tanaka M, Hashiguchi Y, Ueno H, Hase K, Mochizuki H. Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis Colon Rectum 2003; 46: 1054-1059
13. Gregoire M, Garrigue L, Blottiere H, Meflah K. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones. Invasion Metastasis 1992; 12: 185-196
14. Fischer JR, Darjes H, Lahm H, Schindel M, Drings P, Krammer PH. Constitutive secretion of bioactive transforming growth factor β1 by small cell lung cancer cell lines. Eur J Cancer 1994; 30A: 2125-2129
15. Narai S, Watanabe M, Hasegawa H, Nishibori H, Endo T, Kubota T, Kitajima M. Significance of transforming growth factor β1 as a new tumor marker for colorectal cancer. Int J Cancer 2002; 97: 508-511
16. Shim KS, Kim KH, Han WS, Park EB. Elevated serum levels of transforming growth factor-b1 in patients with colorectal carcinoma: Its association with tumor progression and its significant decrease after curative surgical resection. Cancer 1999; 85: 554-561
17. Xiong B, Yuan HY, Hu MB, Zhang F, Wei ZZ, Gong LL, Yang GL. Transforming growth factor-β1 in invasion and metastasis in colorectal cancer. World J Gastroenterol 2002; 8: 674-678
18. Maehara Y, Kakeji Y, Kabashima A, Emi Y, watanabe A, Akazawa K, Baba H, Kohnoe S, Sugimachi K. Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 1999; 17: 607-614
19. Robson H, Anderson E, James RD, Schofield PF. Transforming growth factor beta 1 expression in human colorectal tumors: An independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer 1996; 74: 753-758
20. Bellone G, Carbone A, Tibaudi D, Mauri F, Ferrero I, Smirne C, Suman F, Rivetti C, Migliaretti G, Camandona M, Palestro G, Emanuelli G, Rodeck U. Differential expression of transforming growth factors- β1, -β2 and -β3 in human colon carcinoma. Eur J Cancer 2001; 37: 224-233
21. Tsushima H, Ito N, Tamura S, Matsuda Y, Inada M, Yabuuchi I, Imai Y, Nagashima R, Misawa H, Takeda H, Matsuzawa Y, Kawata S. Circulating transforming growth factor β1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res 2001; 7: 1258-1262